Bunge Global SA - Q1 2026 Earnings Analysis

Performance Highlights

Bunge Global reported Q1 2026 net sales of $21.9 billion, nearly doubling the prior-year $11.6 billion as Viterra's operations are now fully consolidated, representing a substantial top-line beat driven by scale rather than organic pricing strength. However, diluted EPS fell to $0.35 from $1.48 in Q1 2025, as gross profit of $766 million improved only modestly from $597 million despite the revenue surge, indicating significant margin dilution across the enlarged business.

The most consequential operating development was the dramatic expansion of the cost base post-Viterra, with cost of goods sold rising to $21.1 billion and SG&A jumping to $531 million from $380 million, compressing gross margin to 3.5% from 5.1% a year earlier. Segment inventory build was pronounced, with total inventories rising to $15.4 billion from $13.2 billion at year-end, led by Soybean Processing and Refining at $7.5 billion, while a net foreign exchange loss of $94 million versus a $25 million gain in Q1 2025 added further pressure.

Management Outlook and Forward Catalysts

Management has not provided explicit quantitative guidance in the filing, but the Viterra integration thesis centers on realizing synergies across the combined value chain, with goodwill of $3.3 billion reflecting expectations of assembled workforce and operational efficiencies. The IFF specialty ingredients bolt-on acquisition for $105 million, closed March 2026, signals continued strategic investment in higher-value processing capabilities within the Tropical Oils and Specialty Ingredients segment.

The central investor debate heading into Q2 2026 is whether Bunge can convert its dramatically expanded asset base into improved per-unit economics, with bulls focused on synergy capture and harvest-season volume leverage while bears will scrutinize the $541 million operating cash outflow, rising interest expense of $181 million, and elevated leverage as long-term debt climbed to $9.9 billion.